The mouse chorionic gonadotropin β-subunit-like (muCGβ1) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CGβ (rmCGβ)

Shu Qun Shi, Jing Pian Peng, Li Xu, Ying Yang, Yun Chen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background. CGβ is expressed not only in placenta, but also in a wide range of tumors. To study DNA vaccine based on xenogeneic CGβ for cancer immuno-therapy, we investigated whether rhesus monkey CGβ (rmCGβ) DNA vaccine could induce protective T-cell responses and humoral responses in mouse. Methods. We constructed a plasmid containing the rmCGβ coding sequence. Two cloned syngeneic SP2/0 myeloma cell lines that stably express muCGβ1 (SP2/0-muCGβ1) and HN (SP2/0-HN) protein were established. Inoculation of these cell lines was made into mice that had been immunized with DNA vaccine. Specific IgG and IgG type were measured by ELISA and the cytokine expression was detected with RT-PCR. To measure the lymphocyte metabolic activity, the MTS assay was used. Results. After injection of SP2/0-muCGβ into mice that had been immunized with DNA vaccine, a significant increase in the IgG2a specific to the antigen (p < 0.05) and a decrease in the specific IgG1 (p < 0.05) were measured. The expression of TH1 but not TH2 cytokines, including IFN-γ and IL-2, were detected in the splenocytes. However, injection of tumor cells expressing irrelevant or mock molecules into immunized mice could not induce these changes. The survival rate of vaccine-immunized mice injected with SP2/0-muCGβ1 was as high as 58.3% after 55 days. Conclusions. The rmCGβ DNA vaccine has proved to be a potential strategy for protection against tumors with homologous molecules. The muCGβ1 produced by tumors is able to elicit an immunity switch from TH2 to TH1 in vaccinated mice.

Original languageEnglish (US)
Pages (from-to)87-96
Number of pages10
JournalJournal of Gene Medicine
Volume7
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

DNA Vaccines
Chorionic Gonadotropin
Macaca mulatta
Immunity
T-Lymphocytes
Neoplasms
Immunoglobulin G
HN Protein
Cytokines
Cell Line
Injections
Placenta
Interleukin-2
Plasmids
Vaccines
Enzyme-Linked Immunosorbent Assay
Lymphocytes
Antigens
Polymerase Chain Reaction

Keywords

  • CGβ
  • Immuno-protection
  • Switch
  • T-cell immunity
  • Tumor vaccine

ASJC Scopus subject areas

  • Genetics

Cite this

@article{91d1f098e6ed41b399387142b78299d4,
title = "The mouse chorionic gonadotropin β-subunit-like (muCGβ1) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CGβ (rmCGβ)",
abstract = "Background. CGβ is expressed not only in placenta, but also in a wide range of tumors. To study DNA vaccine based on xenogeneic CGβ for cancer immuno-therapy, we investigated whether rhesus monkey CGβ (rmCGβ) DNA vaccine could induce protective T-cell responses and humoral responses in mouse. Methods. We constructed a plasmid containing the rmCGβ coding sequence. Two cloned syngeneic SP2/0 myeloma cell lines that stably express muCGβ1 (SP2/0-muCGβ1) and HN (SP2/0-HN) protein were established. Inoculation of these cell lines was made into mice that had been immunized with DNA vaccine. Specific IgG and IgG type were measured by ELISA and the cytokine expression was detected with RT-PCR. To measure the lymphocyte metabolic activity, the MTS assay was used. Results. After injection of SP2/0-muCGβ into mice that had been immunized with DNA vaccine, a significant increase in the IgG2a specific to the antigen (p < 0.05) and a decrease in the specific IgG1 (p < 0.05) were measured. The expression of TH1 but not TH2 cytokines, including IFN-γ and IL-2, were detected in the splenocytes. However, injection of tumor cells expressing irrelevant or mock molecules into immunized mice could not induce these changes. The survival rate of vaccine-immunized mice injected with SP2/0-muCGβ1 was as high as 58.3{\%} after 55 days. Conclusions. The rmCGβ DNA vaccine has proved to be a potential strategy for protection against tumors with homologous molecules. The muCGβ1 produced by tumors is able to elicit an immunity switch from TH2 to TH1 in vaccinated mice.",
keywords = "CGβ, Immuno-protection, Switch, T-cell immunity, Tumor vaccine",
author = "Shi, {Shu Qun} and Peng, {Jing Pian} and Li Xu and Ying Yang and Yun Chen",
year = "2005",
month = "1",
doi = "10.1002/jgm.633",
language = "English (US)",
volume = "7",
pages = "87--96",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - The mouse chorionic gonadotropin β-subunit-like (muCGβ1) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CGβ (rmCGβ)

AU - Shi, Shu Qun

AU - Peng, Jing Pian

AU - Xu, Li

AU - Yang, Ying

AU - Chen, Yun

PY - 2005/1

Y1 - 2005/1

N2 - Background. CGβ is expressed not only in placenta, but also in a wide range of tumors. To study DNA vaccine based on xenogeneic CGβ for cancer immuno-therapy, we investigated whether rhesus monkey CGβ (rmCGβ) DNA vaccine could induce protective T-cell responses and humoral responses in mouse. Methods. We constructed a plasmid containing the rmCGβ coding sequence. Two cloned syngeneic SP2/0 myeloma cell lines that stably express muCGβ1 (SP2/0-muCGβ1) and HN (SP2/0-HN) protein were established. Inoculation of these cell lines was made into mice that had been immunized with DNA vaccine. Specific IgG and IgG type were measured by ELISA and the cytokine expression was detected with RT-PCR. To measure the lymphocyte metabolic activity, the MTS assay was used. Results. After injection of SP2/0-muCGβ into mice that had been immunized with DNA vaccine, a significant increase in the IgG2a specific to the antigen (p < 0.05) and a decrease in the specific IgG1 (p < 0.05) were measured. The expression of TH1 but not TH2 cytokines, including IFN-γ and IL-2, were detected in the splenocytes. However, injection of tumor cells expressing irrelevant or mock molecules into immunized mice could not induce these changes. The survival rate of vaccine-immunized mice injected with SP2/0-muCGβ1 was as high as 58.3% after 55 days. Conclusions. The rmCGβ DNA vaccine has proved to be a potential strategy for protection against tumors with homologous molecules. The muCGβ1 produced by tumors is able to elicit an immunity switch from TH2 to TH1 in vaccinated mice.

AB - Background. CGβ is expressed not only in placenta, but also in a wide range of tumors. To study DNA vaccine based on xenogeneic CGβ for cancer immuno-therapy, we investigated whether rhesus monkey CGβ (rmCGβ) DNA vaccine could induce protective T-cell responses and humoral responses in mouse. Methods. We constructed a plasmid containing the rmCGβ coding sequence. Two cloned syngeneic SP2/0 myeloma cell lines that stably express muCGβ1 (SP2/0-muCGβ1) and HN (SP2/0-HN) protein were established. Inoculation of these cell lines was made into mice that had been immunized with DNA vaccine. Specific IgG and IgG type were measured by ELISA and the cytokine expression was detected with RT-PCR. To measure the lymphocyte metabolic activity, the MTS assay was used. Results. After injection of SP2/0-muCGβ into mice that had been immunized with DNA vaccine, a significant increase in the IgG2a specific to the antigen (p < 0.05) and a decrease in the specific IgG1 (p < 0.05) were measured. The expression of TH1 but not TH2 cytokines, including IFN-γ and IL-2, were detected in the splenocytes. However, injection of tumor cells expressing irrelevant or mock molecules into immunized mice could not induce these changes. The survival rate of vaccine-immunized mice injected with SP2/0-muCGβ1 was as high as 58.3% after 55 days. Conclusions. The rmCGβ DNA vaccine has proved to be a potential strategy for protection against tumors with homologous molecules. The muCGβ1 produced by tumors is able to elicit an immunity switch from TH2 to TH1 in vaccinated mice.

KW - CGβ

KW - Immuno-protection

KW - Switch

KW - T-cell immunity

KW - Tumor vaccine

UR - http://www.scopus.com/inward/record.url?scp=12744263009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12744263009&partnerID=8YFLogxK

U2 - 10.1002/jgm.633

DO - 10.1002/jgm.633

M3 - Article

VL - 7

SP - 87

EP - 96

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 1

ER -